1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Optic Neuritis Global Clinical Trials Review, H1, 2015

Optic Neuritis Global Clinical Trials Review, H1, 2015

  • January 2015
  • -
  • Global Data
  • -
  • 68 pages

Optic Neuritis Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Optic Neuritis Global Clinical Trials Review, H1, 2015" provides data on the Optic Neuritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Optic Neuritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Optic Neuritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Optic Neuritis Global Clinical Trials Review, H1, 2015
Introduction 6
Optic Neuritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Optic Neuritis to Ophthalmology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Optic Neuritis to Ophthalmology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Optic Neuritis 22
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Optic Neuritis Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Biogen Idec Inc. 29
Clinical Trial Overview of Biogen Idec Inc. 29
Meta-IQ ApS 30
Clinical Trial Overview of Meta-IQ ApS 30
Bionure Farma, S.L. 31
Clinical Trial Overview of Bionure Farma, S.L. 31
Teva Pharmaceutical Industries Limited 32
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 32
Sanofi 33
Clinical Trial Overview of Sanofi 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Merck KGaA 35
Clinical Trial Overview of Merck KGaA 35
MedDay 36
Clinical Trial Overview of MedDay 36
Clinical Trial Overview of Top Institutes / Government 37
Medical University of Vienna 37
Clinical Trial Overview of Medical University of Vienna 37
National Eye Institute 38
Clinical Trial Overview of National Eye Institute 38
Johns Hopkins University 39
Clinical Trial Overview of Johns Hopkins University 39
University of Texas Southwestern Medical Center at Dallas 40
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 40
Isfahan University of Medical Sciences 41
Clinical Trial Overview of Isfahan University of Medical Sciences 41
London Health Sciences Centre 42
Clinical Trial Overview of London Health Sciences Centre 42
Glostrup University Hospital 43
Clinical Trial Overview of Glostrup University Hospital 43
University Medical Center Freiburg 44
Clinical Trial Overview of University Medical Center Freiburg 44
University of Oxford 45
Clinical Trial Overview of University of Oxford 45
Oregon Health and Science University 46
Clinical Trial Overview of Oregon Health and Science University 46
Five Key Clinical Profiles 47
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 68

List of Tables

Optic Neuritis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Optic Neuritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Optic Neuritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Optic Neuritis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Optic Neuritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Optic Neuritis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Optic Neuritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Optic Neuritis to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Optic Neuritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Optic Neuritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Optic Neuritis to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Optic Neuritis Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Optic Neuritis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Optic Neuritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Optic Neuritis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Optic Neuritis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 22
Optic Neuritis Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Optic Neuritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Optic Neuritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Optic Neuritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Optic Neuritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Optic Neuritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2015* 29
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Meta-IQ ApS, 2015* 30
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bionure Farma, S.L., 2015* 31
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2015* 32
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 33
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2015* 35
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by MedDay, 2015* 36
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 37
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 38
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2015* 39
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015* 40
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 41
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by London Health Sciences Centre, 2015* 42
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2015* 43
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Freiburg, 2015* 44
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2015* 45
Optic Neuritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2015* 46

List of Figures

Optic Neuritis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Optic Neuritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Optic Neuritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Optic Neuritis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Optic Neuritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Optic Neuritis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Optic Neuritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Optic Neuritis to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 14
Optic Neuritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Optic Neuritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Optic Neuritis to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 17
Optic Neuritis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Optic Neuritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Optic Neuritis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Optic Neuritis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Optic Neuritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Optic Neuritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Optic Neuritis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Optic Neuritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Optic Neuritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 67

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.